Market revenue in 2021 | USD 4.8 million |
Market revenue in 2030 | USD 34.4 million |
Growth rate | 24.5% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 22.92% in 2021. Horizon Databook has segmented the Russia ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
The country is developing in terms of R&D initiatives, better economy, and technological advancements. Therefore, adoption of AI-based clinical trials solutions in the country is in nascent stage. However, increasing awareness and growing penetration of advanced technologies in the healthcare system of the country are likely to boost adoption of such technologies for clinical trials & clinical research.
The start-up ecosystem in the country is growing at a slower rate as compared to other European countries, mainly owing to lesser funding opportunities and developing healthcare systems in the country.
However, owing to favorable government initiatives and increasing number of large pharmaceutical players entering into the country, the market is anticipated to grow in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the Russia ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Russia ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account